| Title |
Patient views about polypharmacy medication review clinics run by clinical pharmacists in GP practices
|
|---|---|
| Published in |
International Journal of Clinical Pharmacy, October 2017
|
| DOI | 10.1007/s11096-017-0538-z |
| Pubmed ID | |
| Authors |
Rosie Snell, Tim Langran, Parastou Donyai |
| Abstract |
Background Polypharmacy can decrease medication adherence and increase the incidence of adverse drug reactions and drug-drug interactions, resulting in falls, hospitalisations and other complications especially in the elderly. Medication-related problems of polypharmacy can be prevented through patient-centred medication reviews but research in this area has been completed largely without examining patients' viewpoints. Objective The aim was to investigate patient views about a clinical pharmacist-led patient-centred polypharmacy medication review service completed within 17 English GP practices with those ≥ 75 years of age and prescribed ≥ 15 medications, during 415 consultations. Method A patient feedback questionnaire was constructed and face validated with two pharmacists then posted by a Clinical Commissioning Group pharmacist to all patients who had taken part in the service. Data from returned questionnaires were analysed using descriptive statistics and qualitative patient comments were analysed using thematic analysis. Results Of the 166 patients (40% response rate) who returned a feedback questionnaire 83% found the service helpful. Medication-related concerns of 94% who had a concern beforehand were addressed, and 80% understood their medicines better after the review. Patients appreciated pharmacists' personal approach, advice and explanation. Conclusion Patients expressed broadly positive views about polypharmacy reviews by clinical pharmacists within GP practices. |
X Demographics
The data shown below were collected from the profiles of 68 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 31 | 46% |
| Australia | 8 | 12% |
| Spain | 5 | 7% |
| United States | 2 | 3% |
| New Zealand | 1 | 1% |
| Pakistan | 1 | 1% |
| Canada | 1 | 1% |
| Ireland | 1 | 1% |
| Unknown | 18 | 26% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 48 | 71% |
| Scientists | 13 | 19% |
| Practitioners (doctors, other healthcare professionals) | 6 | 9% |
| Science communicators (journalists, bloggers, editors) | 1 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 100 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 100 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 17 | 17% |
| Student > Ph. D. Student | 14 | 14% |
| Researcher | 13 | 13% |
| Student > Bachelor | 12 | 12% |
| Student > Postgraduate | 3 | 3% |
| Other | 8 | 8% |
| Unknown | 33 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 26 | 26% |
| Medicine and Dentistry | 17 | 17% |
| Nursing and Health Professions | 9 | 9% |
| Social Sciences | 3 | 3% |
| Biochemistry, Genetics and Molecular Biology | 2 | 2% |
| Other | 6 | 6% |
| Unknown | 37 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 47. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2022.
All research outputs
#901,531
of 25,744,802 outputs
Outputs from International Journal of Clinical Pharmacy
#20
of 1,600 outputs
Outputs of similar age
#18,537
of 334,687 outputs
Outputs of similar age from International Journal of Clinical Pharmacy
#1
of 18 outputs
Altmetric has tracked 25,744,802 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,600 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 334,687 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.